Selected research
Market Structure
Global Cold Chain Services for Innovative Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cold Chain Services for Innovative Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Cold Chain Services for Innovative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cold Chain Services for Innovative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cold Chain Services for Innovative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cold Chain Services for Innovative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cold Chain Services for Innovative Drug include Marken, World Courier, Cryoport, DTW Logistics, City Express, Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Thermo Fisher, SF Express and Catalent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Cold Chain Services for Innovative Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cold Chain Services for Innovative Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cold Chain Services for Innovative Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cold Chain Services for Innovative Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Cold Chain Services for Innovative Drug Segment by Company
Marken
World Courier
Cryoport
DTW Logistics
City Express
Shanghai Shengsheng Pharmaceutical Cold Chain Technology
Thermo Fisher
SF Express
Catalent
CIMC Cold Cloud
Guoyuan Life Sciences Group
Rochin Logistics
Azenta
Saroute
Cold Chain Services for Innovative Drug Segment by Type
International Transportation
Domestic Transportation
Cold Chain Services for Innovative Drug Segment by Application
Pharmaceutical Companies
Hospitals
Laboratories
Others
Cold Chain Services for Innovative Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cold Chain Services for Innovative Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cold Chain Services for Innovative Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cold Chain Services for Innovative Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cold Chain Services for Innovative Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cold Chain Services for Innovative Drug industry.
Chapter 3: Detailed analysis of Cold Chain Services for Innovative Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cold Chain Services for Innovative Drugrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- International Transportation
- Domestic Transportation
Applications
- Pharmaceutical Companies
- Hospitals
- Laboratories
- Others
Companies covered
- Marken
- World Courier
- Cryoport
- DTW Logistics
- City Express
- Shanghai Shengsheng Pharmaceutical Cold Chain Technology
- Thermo Fisher
- SF Express
- Catalent
- CIMC Cold Cloud
- Guoyuan Life Sciences Group
- Rochin Logistics
- Azenta
- Saroute
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Cold Chain Services for Innovative Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 International Transportation
- 1.2.3 Domestic Transportation
- 1.3 Market Analysis by Application
- 1.3.1 Global Cold Chain Services for Innovative Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Hospitals
- 1.3.4 Laboratories
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Cold Chain Services for Innovative Drug Growth Trends by Region
- 1.5.1 Global Cold Chain Services for Innovative Drug Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Cold Chain Services for Innovative Drug Market Size by Region (2021-2026)
- 1.5.3 Cold Chain Services for Innovative Drug Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Cold Chain Services for Innovative Drug Market Dynamics
- 2.1 Cold Chain Services for Innovative Drug Industry Trends
- 2.2 Cold Chain Services for Innovative Drug Industry Drivers
- 2.3 Cold Chain Services for Innovative Drug Industry Opportunities and Challenges
- 2.4 Cold Chain Services for Innovative Drug Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Cold Chain Services for Innovative Drug Revenue by Company (2021-2026)
- 3.2 Global Cold Chain Services for Innovative Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Cold Chain Services for Innovative Drug Key Company Head office and Area Served
- 3.4 Global Cold Chain Services for Innovative Drug Company, Product Type & Application
- 3.5 Global Cold Chain Services for Innovative Drug Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Cold Chain Services for Innovative Drug Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Cold Chain Services for Innovative Drug Players Market Share by Revenue in 2025
- 3.6.3 2025 Cold Chain Services for Innovative Drug Tier 1, Tier 2, and Tier 3
4 Cold Chain Services for Innovative Drug Market by Type
- 4.1 Global Cold Chain Services for Innovative Drug Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Cold Chain Services for Innovative Drug Market Size by Type (2021-2032)
- 4.3 Global Cold Chain Services for Innovative Drug Market Size Share by Type (2021-2032)
5 Cold Chain Services for Innovative Drug Market by Application
- 5.1 Global Cold Chain Services for Innovative Drug Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Cold Chain Services for Innovative Drug Market Size by Application (2021-2032)
- 5.3 Global Cold Chain Services for Innovative Drug Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Marken
- 6.1.1 Marken Company Information
- 6.1.2 Marken Business Overview
- 6.1.3 Marken Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Marken Cold Chain Services for Innovative Drug Product Portfolio
- 6.1.5 Marken Recent Developments
- 6.2 World Courier
- 6.2.1 World Courier Company Information
- 6.2.2 World Courier Business Overview
- 6.2.3 World Courier Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 World Courier Cold Chain Services for Innovative Drug Product Portfolio
- 6.2.5 World Courier Recent Developments
- 6.3 Cryoport
- 6.3.1 Cryoport Company Information
- 6.3.2 Cryoport Business Overview
- 6.3.3 Cryoport Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Cryoport Cold Chain Services for Innovative Drug Product Portfolio
- 6.3.5 Cryoport Recent Developments
- 6.4 DTW Logistics
- 6.4.1 DTW Logistics Company Information
- 6.4.2 DTW Logistics Business Overview
- 6.4.3 DTW Logistics Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 DTW Logistics Cold Chain Services for Innovative Drug Product Portfolio
- 6.4.5 DTW Logistics Recent Developments
- 6.5 City Express
- 6.5.1 City Express Company Information
- 6.5.2 City Express Business Overview
- 6.5.3 City Express Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 City Express Cold Chain Services for Innovative Drug Product Portfolio
- 6.5.5 City Express Recent Developments
- 6.6 Shanghai Shengsheng Pharmaceutical Cold Chain Technology
- 6.6.1 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Company Information
- 6.6.2 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Business Overview
- 6.6.3 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Product Portfolio
- 6.6.5 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Recent Developments
- 6.7 Thermo Fisher
- 6.7.1 Thermo Fisher Company Information
- 6.7.2 Thermo Fisher Business Overview
- 6.7.3 Thermo Fisher Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Thermo Fisher Cold Chain Services for Innovative Drug Product Portfolio
- 6.7.5 Thermo Fisher Recent Developments
- 6.8 SF Express
- 6.8.1 SF Express Company Information
- 6.8.2 SF Express Business Overview
- 6.8.3 SF Express Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 SF Express Cold Chain Services for Innovative Drug Product Portfolio
- 6.8.5 SF Express Recent Developments
- 6.9 Catalent
- 6.9.1 Catalent Company Information
- 6.9.2 Catalent Business Overview
- 6.9.3 Catalent Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Catalent Cold Chain Services for Innovative Drug Product Portfolio
- 6.9.5 Catalent Recent Developments
- 6.10 CIMC Cold Cloud
- 6.10.1 CIMC Cold Cloud Company Information
- 6.10.2 CIMC Cold Cloud Business Overview
- 6.10.3 CIMC Cold Cloud Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 CIMC Cold Cloud Cold Chain Services for Innovative Drug Product Portfolio
- 6.10.5 CIMC Cold Cloud Recent Developments
- 6.11 Guoyuan Life Sciences Group
- 6.11.1 Guoyuan Life Sciences Group Company Information
- 6.11.2 Guoyuan Life Sciences Group Business Overview
- 6.11.3 Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Product Portfolio
- 6.11.5 Guoyuan Life Sciences Group Recent Developments
- 6.12 Rochin Logistics
- 6.12.1 Rochin Logistics Company Information
- 6.12.2 Rochin Logistics Business Overview
- 6.12.3 Rochin Logistics Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Rochin Logistics Cold Chain Services for Innovative Drug Product Portfolio
- 6.12.5 Rochin Logistics Recent Developments
- 6.13 Azenta
- 6.13.1 Azenta Company Information
- 6.13.2 Azenta Business Overview
- 6.13.3 Azenta Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Azenta Cold Chain Services for Innovative Drug Product Portfolio
- 6.13.5 Azenta Recent Developments
- 6.14 Saroute
- 6.14.1 Saroute Company Information
- 6.14.2 Saroute Business Overview
- 6.14.3 Saroute Cold Chain Services for Innovative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Saroute Cold Chain Services for Innovative Drug Product Portfolio
- 6.14.5 Saroute Recent Developments
7 North America
- 7.1 North America Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 7.2 North America Cold Chain Services for Innovative Drug Market Size by Type
- 7.2.1 North America Cold Chain Services for Innovative Drug Market Size by Type (2021-2026)
- 7.2.2 North America Cold Chain Services for Innovative Drug Market Size by Type (2027-2032)
- 7.2.3 North America Cold Chain Services for Innovative Drug Market Share by Type (2021-2032)
- 7.3 North America Cold Chain Services for Innovative Drug Market Size by Application
- 7.3.1 North America Cold Chain Services for Innovative Drug Market Size by Application (2021-2026)
- 7.3.2 North America Cold Chain Services for Innovative Drug Market Size by Application (2027-2032)
- 7.3.3 North America Cold Chain Services for Innovative Drug Market Share by Application (2021-2032)
- 7.4 North America Cold Chain Services for Innovative Drug Market Size by Country
- 7.4.1 North America Cold Chain Services for Innovative Drug Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Cold Chain Services for Innovative Drug Market Size by Country (2021-2026)
- 7.4.3 North America Cold Chain Services for Innovative Drug Market Size by Country (2027-2032)
- 7.4.4 North America Cold Chain Services for Innovative Drug Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 8.2 Europe Cold Chain Services for Innovative Drug Market Size by Type
- 8.2.1 Europe Cold Chain Services for Innovative Drug Market Size by Type (2021-2026)
- 8.2.2 Europe Cold Chain Services for Innovative Drug Market Size by Type (2027-2032)
- 8.2.3 Europe Cold Chain Services for Innovative Drug Market Share by Type (2021-2032)
- 8.3 Europe Cold Chain Services for Innovative Drug Market Size by Application
- 8.3.1 Europe Cold Chain Services for Innovative Drug Market Size by Application (2021-2026)
- 8.3.2 Europe Cold Chain Services for Innovative Drug Market Size by Application (2027-2032)
- 8.3.3 Europe Cold Chain Services for Innovative Drug Market Share by Application (2021-2032)
- 8.4 Europe Cold Chain Services for Innovative Drug Market Size by Country
- 8.4.1 Europe Cold Chain Services for Innovative Drug Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Cold Chain Services for Innovative Drug Market Size by Country (2021-2026)
- 8.4.3 Europe Cold Chain Services for Innovative Drug Market Size by Country (2027-2032)
- 8.4.4 Europe Cold Chain Services for Innovative Drug Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 9.2 China Cold Chain Services for Innovative Drug Market Size by Type
- 9.2.1 China Cold Chain Services for Innovative Drug Market Size by Type (2021-2026)
- 9.2.2 China Cold Chain Services for Innovative Drug Market Size by Type (2027-2032)
- 9.2.3 China Cold Chain Services for Innovative Drug Market Share by Type (2021-2032)
- 9.3 China Cold Chain Services for Innovative Drug Market Size by Application
- 9.3.1 China Cold Chain Services for Innovative Drug Market Size by Application (2021-2026)
- 9.3.2 China Cold Chain Services for Innovative Drug Market Size by Application (2027-2032)
- 9.3.3 China Cold Chain Services for Innovative Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 10.2 Asia Cold Chain Services for Innovative Drug Market Size by Type
- 10.2.1 Asia Cold Chain Services for Innovative Drug Market Size by Type (2021-2026)
- 10.2.2 Asia Cold Chain Services for Innovative Drug Market Size by Type (2027-2032)
- 10.2.3 Asia Cold Chain Services for Innovative Drug Market Share by Type (2021-2032)
- 10.3 Asia Cold Chain Services for Innovative Drug Market Size by Application
- 10.3.1 Asia Cold Chain Services for Innovative Drug Market Size by Application (2021-2026)
- 10.3.2 Asia Cold Chain Services for Innovative Drug Market Size by Application (2027-2032)
- 10.3.3 Asia Cold Chain Services for Innovative Drug Market Share by Application (2021-2032)
- 10.4 Asia Cold Chain Services for Innovative Drug Market Size by Country
- 10.4.1 Asia Cold Chain Services for Innovative Drug Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Cold Chain Services for Innovative Drug Market Size by Country (2021-2026)
- 10.4.3 Asia Cold Chain Services for Innovative Drug Market Size by Country (2027-2032)
- 10.4.4 Asia Cold Chain Services for Innovative Drug Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Type
- 11.2.1 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Application
- 11.3.1 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Country
- 11.4.1 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Cold Chain Services for Innovative Drug Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst